Number of publications
553
Publications search
  • Cudos, AG; Murillo, SM; Subirats, OP; Villellas, FV; Guzman, DRS; Morales, CC; Olive, JM; Sanchez, AV; Ortega, JFC

    Relapse pattern after neoadjuvant treatment in early breast cancer

    ANNALS OF ONCOLOGY 32 437-437. .

    [doi:10.1016/j.annonc.2021.08.461]

  • Nicolas-Sanchez, FJ; Arostegui-Gorospe, JI; Pallares-Quixal, J; Nicolas-Sarrat, FJ; Sarrat-Nuevo, RM; Bou, RMN; Melgarejo-Moreno, PJ

    p.RQ92 mutation associated with amyloidosis

    REUMATOLOGIA CLINICA 17 46-48. .

    [doi:10.1016/j.reuma.2019.07.006]

  • MATIAS-GUIU GUIA, XAVIER

    Endometrial Cancer Histopathology Reporting Guide

    Endometrial Cancer Histopathology Reporting Guide -. .

  • Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A

    An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.

    GYNECOLOGIC ONCOLOGY 159 721-731. .

    [doi:10.1016/j.ygyno.2020.09.013]

  • Miller RE; Leary A; Scott CL; Serra V; Lord CJ; Bowtell D; Chang DK; Garsed DW; Jonkers J; Ledermann JA; Nik-Zainal S; Ray-Coquard I; Shah SP; Matias-Guiu X; Swisher EM; Yates LR

    ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.

    ANNALS OF ONCOLOGY 31 1606-1622. .

    [doi:10.1016/j.annonc.2020.08.2102]

  • Mellid S; Coloma J; Calsina B; Monteagudo M; Roldán-Romero JM; Santos M; Leandro-García LJ; Lanillos J; Martínez-Montes ÁM; Rodríguez-Antona C; Montero-Conde C; Martínez-López J; Ayala R; Matias-Guiu X; Robledo M; Cascón A

    Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

    Cancers 12 1-12. .

    [doi:10.3390/cancers12113304]

  • Canal Garcia E; Vargas Ramos JDP; Aguayo Ortiz R

    Cellulitis-like Sweet Syndrome caused by adalimumab therapy for severe hidradenitis suppurativa.

    Australasian Journal of Dermatology 61 448-449. .

    [doi:10.1111/ajd.13349]

  • Podlipnik S; Carrera C; Boada A; Richarz N; Marcoval J; Ferreres JR; Bodet D; Martí RM; Segura S; Sabat M; Dalmau J; Quintana M; Azon A; Curcó N; Formigon M; Olivella-Garcés MR; Zaballos P; Sola J; Galvany L; Baliu-Piqué C; Alegre M; Pasquali P; Malvehy J; Puig S

    Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study.

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9113396]

  • Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V

    WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.

    Nature Communications 11 5315-5315. .

    [doi:10.1038/s41467-020-18951-2]

  • Merichal Resina M; Cerdan Santacruz C; Sierra Grañón E; Tarragona Foradada JA; Olsina Kissler JJ

    Anal melanoma, a radical distinct pathology to the cutaneous melanoma, with an infaustic forecast.

    CIRUGIA ESPANOLA 98 491-493. .

    [doi:10.1016/j.ciresp.2019.11.014]

  • Blasco N; Beà A; Barés G; Girón C; Navaridas R; Irazoki A; López-Lluch G; Zorzano A; Dolcet X; Llovera M; Sanchis D

    Involvement of the mitochondrial nuclease EndoG in the regulation of cell proliferation through the control of reactive oxygen species

    Redox Biology 37 101736-101736. .

    [doi:10.1016/j.redox.2020.101736]

  • Cuatrecasas M; Gorostiaga I; Riera C; Saperas E; Llort G; Costa I; Matias-Guiu X; Carrato C; Navarro M; Pineda M; Dueñas N; Brunet J; Marco V; Trias I; Busteros JI; Mateu G; Balaguer F; Fernández-Figueras MT; Esteller M; Musulén E

    Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia.

    Cancers 12 1-20. .

    [doi:10.3390/cancers12102803]